Supplements in the Ozempic Age - Available Now
| | | | | Claim Your Share of the Potential $105 Billion Weight Management Market | | The weight loss market is on the brink of unprecedented transformation. Morgan Stanley projects weight loss pharmaceutical sales to surge from $6 billion in 2023 to $105 billion by 2030, and GLP-1 drugs like Ozempic are leading this revolution. But where does that leave supplement brands? The opportunities are limitless—if you know how to position yourself. |
|
|
|
| NBJ's latest report, Supplements in the Ozempic Age, provides essential insights into the consumer journey across all stages of GLP-1 drug use, from non-users to current users and those who have discontinued. These findings reveal new opportunities for growth in the weight loss and blood sugar management markets. |
|
|
|
| With GLP-1 drugs’ skyrocketing popularity reshaping consumer expectations, this report is your roadmap to capturing market share in this $105 billion future. | | Get the Report |
|
|
|
|
